Cargando…

Understanding Activation and Inhibition of SARS-CoV-2 Viral Entry with Single-Virus Microscopy

Detalles Bibliográficos
Autores principales:	Sengar, Anjali, Morbioli, Giorgio, Kasson, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Biophysical Society 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879820/ http://dx.doi.org/10.1016/j.bpj.2020.11.2028

Ejemplares similares

The ACE2 receptor accelerates but is not biochemically required for SARS-CoV-2 membrane fusion
por: Cervantes, Marcos, et al.
Publicado: (2023)

Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry
por: Sengar, Anjali, et al.
Publicado: (2023)

Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry
por: Guseman, Alex J., et al.
Publicado: (2022)

Targeting spike glycans to inhibit SARS-CoV2 viral entry
por: Guseman, Alex J., et al.
Publicado: (2023)

Structural understanding of SARS-CoV-2 virus entry to host cells
por: Le, Kim, et al.
Publicado: (2023)

Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry
por: Xu, Chuan, et al.
Publicado: (2021)

Tamoxifen and clomiphene inhibit SARS-CoV-2 infection by suppressing viral entry
por: Zu, Shulong, et al.
Publicado: (2021)

Abstract 1509: Targeting Spike Glycans to Inhibit SARS-CoV-2 Viral Entry
por: Guseman, Alex, et al.
Publicado: (2023)

Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration
por: Yang, Qi, et al.
Publicado: (2020)

Direct inhibitory effect on viral entry of influenza A and SARS‐CoV‐2 viruses by azithromycin
por: Du, Xiaohong, et al.
Publicado: (2020)

Impact of Comorbidities on SARS-CoV-2 Viral Entry-Related Genes
por: Breidenbach, Joshua D., et al.
Publicado: (2020)

Trypsin enhances SARS-CoV-2 infection by facilitating viral entry
por: Kim, Yeeun, et al.
Publicado: (2022)

Characteristic patterns of SARS-CoV-2 on chest CT suggests a hematologic pathway for viral entry into the lung
por: Salvatore, Mary M., et al.
Publicado: (2022)

SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry
por: Yang, Bo, et al.
Publicado: (2022)

VE607 stabilizes SARS-CoV-2 Spike in the “RBD-up” conformation and inhibits viral entry
por: Ding, Shilei, et al.
Publicado: (2022)

Elucidating coronavirus fusion mechanisms
por: Hess, Tobin, et al.
Publicado: (2023)

Application of pseudotyped virus particles to monitor Ebola virus and SARS-CoV-2 viral entry in human cell lines
por: Eichler, Madeleine, et al.
Publicado: (2021)

Identification of a New Region of SARS-CoV S Protein Critical for Viral Entry
por: Guo, Ying, et al.
Publicado: (2009)

Preparation of SARS-CoV-2 VLP to study viral assembly, egress, and entry
por: Petersen, Jennifer D., et al.
Publicado: (2022)

SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
por: Sanders, David W, et al.
Publicado: (2021)

An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research
por: Yang, Peng, et al.
Publicado: (2021)

Botanical inhibitors of SARS-CoV-2 viral entry: a phylogenetic perspective
por: Risener, Caitlin J., et al.
Publicado: (2023)

Herbal Compounds Dauricine and Isoliensinine Impede SARS-CoV-2 Viral Entry
por: Dabrell, Shaneek Natoya, et al.
Publicado: (2023)

Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry.
por: Yuan, Zixuan, et al.
Publicado: (2020)

Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus
por: Behzadipour, Yasaman, et al.
Publicado: (2022)

Inhibition of SARS-CoV-2 Virus Entry by the Crude Polysaccharides of Seaweeds and Abalone Viscera In Vitro
por: Yim, Sung-Kun, et al.
Publicado: (2021)

SARS-CoV, But not HCoV-NL63, Utilizes Cathepsins to Infect Cells: Viral Entry
por: Huang, I-Chueh, et al.
Publicado: (2006)

In silico study of the inhibition of SARS-COV-2 viral cell entry by neem tree extracts
por: Shadrack, Daniel M., et al.
Publicado: (2021)

Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
por: Kastenhuber, Edward R, et al.
Publicado: (2022)

Amuvatinib Blocks SARS-CoV-2 Infection at the Entry Step of the Viral Life Cycle
por: Huynh, Trang T. X., et al.
Publicado: (2023)

Cell entry by SARS-CoV-2
por: Peng, Ruchao, et al.
Publicado: (2021)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
por: Condor Capcha, Jose Manuel, et al.
Publicado: (2021)

SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles
por: Plescia, Caroline B., et al.
Publicado: (2020)

The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion
por: Chen, Ting-Hsu, et al.
Publicado: (2023)

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
por: Tandon, Ritesh, et al.
Publicado: (2020)

LRRC15 inhibits SARS-CoV-2 cellular entry in trans
por: Song, Jaewon, et al.
Publicado: (2022)

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2020)

Potent Inhibition of Viral Entry and Replication of SARS-CoV by siRNAs Targeting the Genes Encoding the Cellular ACE2 Receptor or the Viral Nucleocapsid Protein
por: Yan, Xin, et al.
Publicado: (2007)

C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein
por: Gargantilla, Marta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fhdlb1mrfmsgoq3mp1lcbh1il7